Header

Skip to main content

Sensei Biotherapeutics

Sensei Biotherapeutics is an immuno-oncology company that is dedicated to understanding and selectively interacting with the tumor microenvironment in order to tilt the immune system against cancer.

NovaBridge Biosciences

NovaBridge Biosciences is a biotechnology platform that develops precision immuno-oncology treatment of cancer.

Io Biotech

IO Biotech is a clinical stage biotech company developing disruptive immune therapies for immunological treatment of cancer.

Immunomic Therapeutics

Immunomic Therapeutics, Inc. (ITI) is a privately-held clinical stage biotechnology company pioneering the study of the Universal Intracellular Targeted Expression (UNITE) nucleic acid immunotherapy platform.

Creative Bio-Peptides

Creative Bio-Peptides develops oral peptide-based immunotherapies designed to modulate innate immune and regenerative pathways.

Amgen Rockville

Amgen Rockville is a biopharmaceutical that discovers, develops and commercializes antibody therapies for treating cancer, inflammatory, and autoimmune diseases.

Arcellx

Arcellx is a clinical-stage biotechnology company reimagining cell therapy through the development of innovative immunotherapies.

AbelZeta

AbelZeta is a biopharmaceutical company that develops immune cell therapies for the treatment of cancerous diseases.

This website uses cookies

This site uses cookies to provide more personalized content, social media features, and ads, and to analyze our traffic. We might share information about your use of our site with our social media, advertising, and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services. We will never sell your information or share it with unaffiliated entities.